TipRanks
Niagen Bioscience (DE:OCD1)
FRANKFURT:OCD1
Germany Market
OCD1
Niagen Bioscience
RESEARCH TOOLSreports

Niagen Bioscience (OCD1) Balance Sheet

2 Followers

Niagen Bioscience Balance Sheet

Niagen Bioscience's total assets for Q2 2026 were $106.59M, a decrease of -6.77% from the previous quarter. DE:OCD1 total liabilities were $24.06M for the fiscal quarter, a -24.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 106.41M$ 68.28M$ 54.96M$ 54.06M$ 57.84M
Total Liabilities
$ 29.87M$ 22.18M$ 26.51M$ 25.39M$ 26.11M
Total Equity Gross Minority
$ 76.53M$ 46.09M$ 28.46M$ 28.67M$ 31.73M
Other Metrics
Currency in USD

Niagen Bioscience Debt to Assets